The path ahead for the FDA
In a Coalition for Healthcare Communication webinar, former FDA exec Nancy Bradish Myers reflected on the agency’s tumultuous 2020 and charted a path forward for 2021.
In a Coalition for Healthcare Communication webinar, former FDA exec Nancy Bradish Myers reflected on the agency’s tumultuous 2020 and charted a path forward for 2021.
The government agency is looking for firms to continue work started in 2014 with several add-ons.
Dr. Charlotte Jones-Burton, VP of Otsuka and president and co-founder of WOCIP, weighs in on recent statements concerning Vice-President-elect Kamala Harris’ Black heritage, and offers her take on other news.
The agency will issue its final verdict on approval in March.
In this episode, Bakul Patel speaks about the agency’s new Digital Health Center of Excellence.
The agency sent warning letters to vape companies selling e-cigarettes without premarket authorization.
The comms veteran, who found himself at the center of a feud between the commissioner and HHS, also discusses concerns about the agency’s independence.
Pharma companies pledge to only seek approval for safe and effective COVID-19 vaccines; A vaccine before the November election is unlikely, Fauci says; Uber Health head to depart.
FDA may grant emergency use of a vaccine before trials end; Most Americans believe COVID-19 vaccine approval is driven by politics; Aimmune to be acquired by Nestle.
FDA grants emergency use authorization for plasma in treatment of COVID-19; NIH to study another Gilead coronavirus drug candidate; First documented case of reinfection with COVID-19 raises questions.